Insider Transactions in Q2 2022 at Karyopharm Therapeutics Inc. (KPTI)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 13
2022
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,551
-0.85%
|
$7,755
$5.27 P/Share
|
|
Jun 10
2022
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
1,307
-0.08%
|
$7,842
$6.0 P/Share
|
|
Jun 09
2022
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
211,500
-10.92%
|
$1,269,000
$6.18 P/Share
|
|
Jun 08
2022
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
325,977
-14.4%
|
$1,955,862
$6.5 P/Share
|
|
Jun 07
2022
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
2,542
-0.4%
|
$12,710
$5.76 P/Share
|
|
Jun 03
2022
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
601
-0.22%
|
$3,606
$6.06 P/Share
|
|
May 04
2022
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
28,502
-2.15%
|
$171,012
$6.25 P/Share
|
|
Apr 29
2022
|
Reshma Rangwala EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,000
+50.0%
|
-
|